Module 2 - Fine-tuning your outcomes in refractive cataract surgery
December 31, 2022
The accreditation for this activity has expired.
Primary Audience:
These activities are intended for fellows and new-to-practice ophthalmologists who perform cataract and refractive surgeries.
Relevant Terms:
Refractive Cataract Surgery
Francis S. Mah, MD
Director of Corneal and External Disease
Co-Director of Refractive Surgery
Scripps Clinic
La Jolla, CA
Francis Mah, MD, is an ophthalmologist specializing in advanced corneal, cataract and refractive surgery. He believes in using the latest techniques to treat each patient with compassion and respect, just as though they were members of his own family. Dr. Mah has special clinical interests in corneal diseases and infections, corneal transplant surgery (DSAEK, PKP, DALK), advanced small incision laser cataract surgery, premium intraocular lenses, and refractive surgery, such as LASIK and PRK.
Dr. Mah treats corneal dystrophies, such as Fuchs’ endothelial dystrophy and anterior stromal dystrophies, as well as keratoconus and other corneal thinning disorders. In addition, he has done research and is considered an international expert on corneal infections (bacterial, viral, fungal, and parasitic).
He holds leadership positions in ophthalmology academies and societies and has taught LASIK and cataract surgery at academy and society meetings worldwide. A popular speaker who has delivered addresses on ophthalmic surgeries in more than 50 countries on 6 continents, Dr. Mah is an esteemed educator who has disseminated his expertise through more than 200 presentations and clinical publications.
Dr. Mah was selected as a “Top Doctor” for 2013. This is the 10th consecutive year the San Diego County Medical Society and San Diego Magazine have compiled this esteemed list of board-certified physicians who are held in the highest regard by their peers.
When he is not providing care to patients, Dr. Mah enjoys playing tennis with his oldest son, golf with his younger son, swimming with his daughter, and practicing yoga with his wife.
Dagny Zhu, MD
Cornea, Cataract & Refractive Surgeon
Medical Director & Owner, NVISION Eye Centers
Rowland Heights, CA
Dr. Zhu was born in Shanghai, China and immigrated to the United States with her working-class parents at the age of 3. As a Southern California native, Dr. Zhu graduated top of her high school class as valedictorian and attended UCLA on a full-tuition Regents scholarship (the highest award granted in the UC system) where she graduated Summa Cum Laude with a degree in molecular, cell, and developmental biology.
Dr. Zhu received her M.D. from Harvard Medical School where she discovered her love for ophthalmology and performed cutting-edge research on corneal immunology at Harvard’s Massachusetts Eye and Ear Infirmary. As a medical student, she co-founded the Medical Mandarin course for doctors-in-training and embarked on a medical mission with Operation Burns in Mumbai, India where she worked alongside plastic surgeons to treat burn victims with debilitating skin and eyelid contractures. Dr. Zhu then returned to Southern California to complete her ophthalmology residency at the prestigious Doheny Eye Institute/University of Southern California (USC) & Los Angeles County Medical Center, where she served a predominantly Latino community and cared for the sickest patients at one of the largest public hospitals in the country. Described as a “gifted surgeon” by her mentors, Dr. Zhu elected to complete fellowship training in cornea and refractive surgery at Bascom Palmer Eye Institute, the #1 eye hospital in the world.
This activity is supported by independent educational grants from Alcon and Johnson & Johnson Vision.
Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Policy
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Francis S. Mah, MD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant: Alcon, Allergan/AbbVie, Dompé, Johnson & Johnson Vision, Kiova, Novartis, Santen, and Sun Pharmaceutical Industries. Speaker’s Bureau: Dompé, Johnson & Johnson Vision, Santen, Sun Pharmaceutical Industries, and Tarsus Pharmaceuticals.
Dagny Zhu, MD, has had a financial agreement or affiliation during the past year with the following ineligible companies in the form of Consultant: Alchemy Vision, Alcon, Allergan/Abbvie, Bausch & Lomb, Bruder, Bryn Mawr Communications, Entelexo, Eyesafe, Eyenovia, IrisVision, Johnson & Johnson, Lensar, Ocuphire, Sight Sciences, Tarsus Pharmaceuticals, and Visus Therapeutics. Grant/Research Support: Alcon and Lensar. Speakers Bureau: Allergan/Abbvie and Santen. Shareholder: Glaukos.
The Evolve staff and planners have no financial relationships with ineligible companies.
Nisha Mukherjee, MD, peer reviewer, has no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Alcon or Johnson & Johnson Vision.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
